Scientific consulting firm Exponent (NASDAQ:EXPO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 19.1% year on year to $147.4 million. Its GAAP profit of $0.49 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results